(Q35917442)

11 August 2017

Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol (English)

1 reference

11 August 2017

1 reference

9

Harald Jüppner

1 reference

11 August 2017

10

Myles Wolf

1 reference

11 August 2017

Tamara Isakova

1

1 reference

11 August 2017

Huiliang Xie

2

1 reference

11 August 2017

Allison Barchi-Chung

3

1 reference

11 August 2017

Kelsey Smith

4

1 reference

11 August 2017

Nicole Sowden

5

1 reference

11 August 2017

Michael Epstein

6

1 reference

11 August 2017

Gina Collerone

7

1 reference

11 August 2017

Leigh Keating

8

1 reference

11 August 2017

1 March 2012

1 reference

Clinical Journal of the American Society of Nephrology

11 August 2017

1 reference

11 August 2017

7

1 reference

11 August 2017

5

1 reference

11 August 2017

820-828

1 reference

FGF23 induces left ventricular hypertrophy

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Effects of dietary phosphate and calcium intake on fibroblast growth factor-23

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Chronic kidney disease and bone fracture: a growing concern

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Association of oral calcitriol with improved survival in nondialyzed CKD.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Net intestinal absorption of calcium in patients with chronic renal failure.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Determinants of parathyroid hormone levels in nursing home residents

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338283

Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency

22 October 2018

1 reference

12 December 2020

Risk factors for secondary hyperparathyroidism in a nursing home population

1 reference

12 December 2020

The parathyroid hormone circadian rhythm is truly endogenous--a general clinical research center study

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.11721111

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22383746

1 reference